Moorpark, Calif. – March 15, 2022 – Telebionix, makers of Remosense, an AI-driven biometric device and fully integrated end-to-end health ecosystem – are raising funds through an equity crowdfunding campaign on Wefunder. Telebionix is seeking to raise $50,000 to help bring the Remosense integrated healthcare ecosystem, which will help improve the patient care quality in the comfort of their homes, while cutting healthcare costs dramatically, to market.
Telebionix is a MedTech innovation company headquartered in Southern California. Their central objective is to develop smart medical devices to provide customers with simple, effective, accurate life-saving products and health tracking technologies. Their vision focuses on building solution platforms that empower people to reach a higher quality of life, well-being, mental and physical health, and enjoy happier lives.
Telebionix is dedicated to improving the quality of life for patients and caregivers by developing remote, AI-driven medical devices that are easy to use and clinically grade. They have created a suite of solutions for both care providers and their patients in order to provide better care at home or in the field. Their technology can be used by anyone with limited mobility, like older adults or those who live in remote areas around the world, as well as doctors for proactive diagnosis.
Their flagship product is Remosense, the first all-in-one biometric device powered by artificial intelligence to measure multiple biomarkers such as SPO2, Heart Rate, Blood Pressure, Body temperature, ECG, and Stethoscope, with AI-driven cross-modality analysis. Remosense is a clinical-grade, smart, handheld device allowing patients to collect accurate and precise measurements on key vital signs anywhere, and instantly relay them to their clinician. This portable system has a flexible architecture making it a personal health tracking and a telehealth tool empowering patients with real-time biomarkers and share with healthcare professionals.
“Our goal is to use the funds raised from our Wefunder campaign to help bring Remosense to the global market because we know it is going to change the healthcare industry for the better,” said Telebionix Co-founder and CEO Widy Medina. “Overall, we believe Remosense will provide value for both patients and doctors by giving back piece-of-mind and control to patients who need healthcare services from the comfort of their homes.”
Remosense is simple to use, reliable, and secure by design. It reads and provides accurate, precise and repeatable information for better remote care while collecting and storing information for ongoing monitoring. Remosense leverages Telebionix’s proprietary algorithms for improved sensing accuracy that includes increased SPO2 accuracy by analyzing skin tone prior to measurement, expanded stethoscope analytics, stethoscope microphone self-calibration, and unique algorithms for blood pressure determination. It can also predict health conditions as its consolidated biomarker data couples with professional diagnostic labels to create a unique data set. This data is correlated using AI, and it will create a powerful analysis that will evolve into a predictability model in the future.
Telebionix is currently developing a plan for ongoing improvements to Remosense, and funding from the Wefunder campaign will fuel development.
“We believe that the future of digital health is the ability to move from reactive to predictive and proactive. Remosense platform predicts medical conditions and saves lives,” said Telebionix Co-founder and COO Aghiath Chbib. “The overall goal is to continue improving the capability of our health platform to become the best medical conditions predictive tool available on the market.”
Telebionix’s equity crowdfunding campaign is now open on Wefunder.
About Telebionix’s Founders:
Telebionix is founded by CEO Widy Medina and COO Aghiath Chbib.
Medina is an innovator with over 25 years of experience who has founded and led two technology companies. He has vast experience in robotics, product design, fabrication, automation to electronic assembly of consumer products, food and beverage tech, biotech, medical devices and pharmaceutical industries. Medina is passionate for quality in every customer touchpoint, user experience, and transformative technologies for a higher quality of life.
Chbib is a serial entrepreneur equipped with 22 years of success driving global business development, channel sales and distribution, growth in large, multimillion-dollar organizations and private start-ups. He has managed large accounts for government agencies and organizations, including telecommunications and financial companies across Europe, the Middle East, and North Africa. He is an award-winning expert in cybersecurity and recognized as one of the Top 50 Global Thought Leaders and Influencers. He is an author in Intelligenthq, Openbusinesscouncil, bizcatalyst360, and Hedgethink.
About Telebionix:
Telebionix is a MedTech innovation company that develops smart medical devices to provide customers with simple, effective, accurate life-saving products and health tracking technologies. Their vision focuses on building solution platforms that empower people to reach a higher quality of life, well-being, mental and physical health, and enjoy happier lives.
Telebionix is dedicated to improving the quality of life for patients and caregivers by developing remote, AI-driven medical devices that are easy to use and clinically grade. They have created a suite of solutions for both care providers and their patients in order to provide better care at home or in the field. Their technology can be used by anyone with limited mobility, like older adults or those who live in remote areas around the world, as well as doctors for proactive diagnosis.
Media Contact
Company Name: Telebionix
Contact Person: Barbara Perez
Email: Send Email
Phone: 607 422 8505
Address:10089 Stockton Rd.
City: Moorpark
State: CA 93021
Country: United States
Website: https://telebionix.com